We evaluated that 1) serum BACE1 activity increases in AD, 2) it increases at an earlier stage as in MCI-AD, 3) it can detect cognitive decline before AD diagnosis with high sensitivity and specificity, and 4) it performs better than the serum Aβ assay. This evidence concerns the gene BACE1 and Mental deterioration.